Wyeth Pharmaceuticals Inc., a Pfizer Inc. subsidiary, agreed to a $490.9 million settlement with the U.S. Department of Justice last month to resolve civil and criminal allegations of off-la... Read more
On April 3, 2013, the First Circuit Court of Appeals ruled that drug manufacturer Pfizer, Inc.’s fraudulent marketing of the drug Neurontin directly caused plaintiffs Kaiser Foundation Healt... Read more
AstraZeneca, facing declining revenues last year, sold the marketing rights to its over-the-counter (OTC) version of Nexium to Pfizer Inc. for $250 million. AstraZeneca will be in line for m... Read more
Kentucky has reached a settlement with pharmaceutical giant Pfizer, Inc. over the illegal off-label marketing of its urology drug Detrol. The settlement concludes a government investigation... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.